Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection

The Journal of Experimental Medicine
Haiyin LiuJustine D Mintern


Major histocompatibility complex class II (MHC II) expression is tightly regulated, being subjected to cell type-specific mechanisms that closely control its levels at the cell surface. Ubiquitination by the E3 ubiquitin ligase MARCH 1 regulates MHC II expression in dendritic cells and B cells. In this study, we demonstrate that the related ligase MARCH 8 is responsible for regulating surface MHC II in thymic epithelial cells (TECs). March8(-/-) mice have elevated MHC II at the surface of cortical TECs and autoimmune regulator (AIRE)(-) medullary TECs (mTECs), but not AIRE(+) mTECs. Despite this, thymic and splenic CD4(+) T cell numbers and repertoires remained unaltered in March8(-/-) mice. Notably, the ubiquitination of MHC II by MARCH 8 is controlled by CD83. Mice expressing a mutated form of CD83 (Cd83(anu/anu) mice) have impaired CD4(+) T cell selection, but deleting March8 in Cd83(anu/anu) mice restored CD4(+) T cell selection to normal levels. Therefore, orchestrated regulation of MHC II surface expression in TECs by MARCH 8 and CD83 plays a major role in CD4(+) T cell selection. Our results also highlight the specialized use of ubiquitinating machinery in distinct antigen-presenting cell types, with important functional...Continue Reading


Jan 11, 2000·Nucleic Acids Research·M P Lefranc
Apr 17, 2002·Cell·Yoko FujimotoThomas F Tedder
Jun 21, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Mari Ohmura-HoshinoSatoshi Ishido
Sep 7, 2006·Journal of Biochemistry·Mari Ohmura-HoshinoSatoshi Ishido
Jan 27, 2007·The EMBO Journal·Yohei MatsukiSatoshi Ishido
May 16, 2007·The Journal of Experimental Medicine·Simona W RossiGraham Anderson
Sep 7, 2007·International Immunology·Yoshihiro KuwanoThomas F Tedder
Oct 3, 2007·The Journal of Experimental Medicine·Daniel H GrayDiane Mathis
Feb 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Aude De GassartEvelina Gatti
Nov 15, 2008·Nature Reviews. Immunology·Pärt PetersonAna Rebane
Jan 2, 2009·The Journal of Biological Chemistry·Nicolas LapaqueAdrian P Kelly
Mar 24, 2009·Annual Review of Immunology·Diane Mathis, Christophe Benoist
Nov 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Even WalsengPaul A Roche
Dec 8, 2010·The Journal of Clinical Investigation·Pradyot DashPaul G Thomas
Jan 12, 2011·The Journal of Experimental Medicine·Lina E TzeChristopher C Goodnow
May 9, 2012·Proceedings of the National Academy of Sciences of the United States of America·Jessica MaIra Mellman
Sep 8, 2012·Nature Reviews. Immunology·James F Mohan, Emil R Unanue
Nov 28, 2012·Current Opinion in Immunology·Jessica M MoffatJose A Villadangos
May 29, 2013·The Journal of Experimental Medicine·Jaehak OhJeoung-Sook Shin
Dec 7, 2013·Frontiers in Immunology·Kyung-Jin Cho, Paul A Roche
May 17, 2014·Nature Reviews. Immunology·Ludger KleinKristin A Hogquist
Nov 5, 2014·Current Protocols in Immunology·Reema Jain, Daniel H Gray
Feb 6, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anika ReuterJustine D Mintern


Mar 21, 2017·Nature Reviews. Immunology·Yousuke TakahamaGraham Anderson
Nov 12, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xinsheng JuDerek N J Hart
Mar 8, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kensuke TakadaYousuke Takahama
Sep 6, 2017·Immunology·Geraldo A PassosDaniella A Mendes-da-Cruz
Nov 27, 2018·International Immunology·Kenta KondoYousuke Takahama
Nov 1, 2018·Immunogenetics·Satoshi Ishido, Mizuho Kajikawa
Jun 25, 2019·Frontiers in Immunology·Ziduo LiGeorgina J Clark
Dec 6, 2019·Nature Reviews. Immunology·Noam KadouriJakub Abramson
Aug 23, 2017·Immunology and Cell Biology·Justine D Mintern, Jose A Villadangos
Aug 5, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Haiyin LiuJustine D Mintern
Jul 12, 2017·The Journal of Experimental Medicine·Andrea J WhiteGraham Anderson
May 12, 2017·Frontiers in Immunology·Katrin Regina Helene PackhäuserDamián Oscar Muzzio
Jun 6, 2017·The Journal of Clinical Investigation·Themis AlissafiPanayotis Verginis
Sep 19, 2019·JCI Insight·Andreas B WildAlexander Steinkasserer

Related Concepts

Cd83 protein, mouse
C-MIR protein, mouse
Immune-Associated Antigens
Epithelial Cells
Membrane Glycoproteins
Mice, Inbred C57BL
Thymus Gland
CD4 Positive T Lymphocytes

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.